Progyny, Inc. (NASDAQ:PGNY – Get Rating) CEO Peter Anevski sold 16,000 shares of the firm's stock in a transaction on Thursday, August 11th. The shares were sold at an average price of $44.68, for a total value of $714,880.00. Following the transaction, the chief executive officer now owns 324,916 shares in the company, valued at approximately $14,517,246.88. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Peter Anevski also recently made the following trade(s):
Get Progyny alerts:- On Tuesday, August 9th, Peter Anevski sold 16,000 shares of Progyny stock. The shares were sold at an average price of $41.64, for a total transaction of $666,240.00.
- On Monday, June 27th, Peter Anevski sold 80 shares of Progyny stock. The shares were sold at an average price of $31.21, for a total transaction of $2,496.80.
Progyny Stock Up 1.6 %
Shares of NASDAQ:PGNY opened at $45.01 on Friday. The firm has a 50 day moving average of $31.47 and a 200 day moving average of $37.53. The company has a market capitalization of $4.14 billion, a price-to-earnings ratio of 97.85, a price-to-earnings-growth ratio of 12.14 and a beta of 1.85. Progyny, Inc. has a 52 week low of $25.67 and a 52 week high of $68.32.
Progyny (NASDAQ:PGNY – Get Rating) last released its quarterly earnings results on Thursday, August 4th. The company reported $0.09 EPS for the quarter, topping the consensus estimate of $0.05 by $0.04. The firm had revenue of $195.00 million during the quarter, compared to analyst estimates of $190.51 million. Progyny had a return on equity of 17.11% and a net margin of 7.39%. During the same period in the previous year, the company posted $0.19 EPS. The business's revenue for the quarter was up 51.5% compared to the same quarter last year. On average, sell-side analysts expect that Progyny, Inc. will post 0.17 EPS for the current year.Institutional Trading of Progyny
Hedge funds have recently modified their holdings of the company. National Bank of Canada FI purchased a new position in shares of Progyny in the 2nd quarter worth approximately $29,000. First Horizon Advisors Inc. boosted its stake in Progyny by 1,469.4% in the fourth quarter. First Horizon Advisors Inc. now owns 769 shares of the company's stock valued at $38,000 after acquiring an additional 720 shares in the last quarter. Fifth Third Bancorp increased its position in shares of Progyny by 1,532.4% during the fourth quarter. Fifth Third Bancorp now owns 1,208 shares of the company's stock worth $61,000 after purchasing an additional 1,134 shares in the last quarter. Steward Partners Investment Advisory LLC lifted its holdings in shares of Progyny by 44.8% during the 4th quarter. Steward Partners Investment Advisory LLC now owns 1,209 shares of the company's stock valued at $61,000 after purchasing an additional 374 shares during the last quarter. Finally, Lazard Asset Management LLC acquired a new stake in shares of Progyny in the 1st quarter worth $62,000. 82.51% of the stock is owned by hedge funds and other institutional investors.
About Progyny
(Get Rating)
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
Further Reading
- Get a free copy of the StockNews.com research report on Progyny (PGNY)
- MarketBeat: Week in Review 8/8 – 8/12
- 2 Important Retail Stock Battles to Watch
- What Is WallStreetBets and What Stocks Are They Targeting?
- Institutions And Analysts Propel Jack In The Box Higher
- Can You Guess Which EV Stock Is Beating Tesla ?
Receive News & Ratings for Progyny Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Progyny and related companies with MarketBeat.com's FREE daily email newsletter.